PL EN


2016 | 3 | 291-293
Article title

Disorders of carbohydrate metabolism and their relationship with the prevalence of cancer in patients with acromegaly – authors’ own observations

Content
Title variants
Languages of publication
EN
Abstracts
Contributors
References
  • Kałużny M, Bolanowski M. Acromegaly – a possible cause of diagnostic errors in family doctor’s practice. Fam Med Prim Care Rev 2009; 11(2): 173–178.
  • Bolanowski M, Ruchała M, Zgliczyński W, et al. Acromegaly – a novel view of the patient. Polish propos al of diagnostics and therapeutic procedure in the light of recent reports. Endokrynol Pol 2014; 65(4): 326–331, doi: 10.5603/EP.2014.0045.
  • Bolanowski M, Kałużny M, Jawiarczyk A. Akromegalia – możliwe trudności diagnostyczne w praktyce lekarza rodzinnego.Fam Med Prim Care Rev 2010; 12(2): 317–319.
  • Nomiyama T, Yanase T. Secondary diabetes. Nihon Rinsho 2015; 73(12): 2008–2012 (Abstract).
  • Urbani C, Sardella C, Calevro A, et al. Effects of medical therapies for acromegaly on glucose metabolism. Eur J Endocrinol 2013; 169(1): 99–108, doi: 10.1530/EJE-13-0032.
  • Møller N, Jørgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 2009; 30(2): 152–177, doi: 10.1210/er.2008-0027.
  • Valea A, Carsote M, Ghervan C, et al. Glycemic profile in patients with acromegaly treated with somatostatin analogue. J Med Life 2015; 8 Spec. Issue: 82–86.
  • LeRoith D, Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 2007; 3(3): 302–310.
  • Colao A, Ferone D, Marzullo P, et al. Systemic complications of acromegaly: epidemiology, pathogenesis, and management.Endocr Rev 2004; 25(1): 102–152.
  • Jenkins PJ, Besser M. Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab 2001; 86(7): 2935–2941.
  • Alexopoulou O, Bex M, Kamenicky P, et al. Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 1488 patients. Pituitary 2014; 17(1): 81–89, doi: 10.1007/s11102-013-0471-7.
  • Wen-Ko C, Szu-Tah C, Feng-Hsuan L, et al. The impact of diabetes mellitus on the survival of patients with acromegaly.Endokrynol Pol 2016; Feb 17, doi: 10.5603/EP.a2016.0031. [Epub ahead of print].
  • Zieleniewski W, Michalak R. Akromegalia – niedoceniony problem zdrowotny w praktyce lekarza rodzinnego. Fam Med Prim Care Rev 2011; 13(2): 273–275.
  • Bensimon L, Yin H, Suissa S, et al. Type 2 diabetes and the risk of mortality among patients with prostate cancer. Cancer Causes Control 2014; 25(3): 329–338, doi: 10.1007/s10552-013-0334-6.
  • Khandwala HM, McCutcheon IE, Flyvbjerg A, et al. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000; 21(3): 215–244.
  • Ruchała M, Szczepanek-Parulska E. Rak tarczycy a akromegalia. Thyroid International 2015; 1: 3–11.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.desklight-39529c92-1888-4d28-8d2d-72bcf7de67e7
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.